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Migraine is a common neurovascular brain disorder that ismanifested in recurrent episodes of disabling headache.
The aim of the present study was to compare the prevalence
and heritability of migraine across six of the countries that par-
ticipate in GenomEUtwin project including a total number of
29,717 twin pairs. Migraine was assessed by questionnaires
that differed between most countries. It was most prevalent in
Danish and Dutch females (32% and 34%, respectively),
whereas the lowest prevalence was found in the younger and
older Finnish cohorts (13% and 10%, respectively). The esti-
mated genetic variance (heritability) was significant and the
same between sexes in all countries. Heritability ranged from
34% to 57%, with lowest estimates in Australia, and highest
estimates in the older cohort of Finland, the Netherlands, and
Denmark. There was some indication that part of the genetic
variance was non-additive, but this was significant in Sweden
only. In addition to genetic factors, environmental effects that
are non-shared between members of a twin pair contributed to
the liability of migraine. After migraine definitions are homoge-
nized among the participating countries, the GenomEUtwin
project will provide a powerful resource to identify the genes
involved in migraine. 
Migraine is considered to be a brain disorder of neurovas-
cular origin that is manifested by recurrent episodes of
disabling headache. These episodes last for about a day and
the pain intensity is usually experienced as moderate or
severe. Throbbing and pounding headache is typically
accompanied by nausea, vomiting, and hypersensitivity to
sound and light. In addition, about a third of migraine suf-
ferers experience aura symptoms that are characterized by
visual, sensory, motor or speech-related disturbances that
precede the headache (e.g., Russell et al., 1996).
Epidemiological studies indicate that the peak incidence is
during adolescence, with a slightly later onset in females
than in males (Steward et al., 1994). Lifetime prevalence is
15% in migraine without aura and 8% in migraine with
aura. A two to threefold female preponderance in adult
prevalence as well as associations with events of the female
reproductive cycle, suggests a triggering effect of hormones
(e.g., Massiou & Bousser, 2000).
Pathophysiology
As with most common complex diseases, migraine is
thought to have a multifactorial basis. Although the patho-
genesis has not yet been completely elucidated, some
mechanisms have been proposed that could explain the
migraine headache and aura symptoms. A key role is
ascribed to the trigeminovascular system and associated
brainstem nuclei. Aberrant activation of the brainstem gives
rise to central transmission of pain and a cascade of bio-
chemical events involving the release of neuropeptides,
which leads to sterile neurogenic inflammation, vasodila-
tion in the dura mater and vascular headache. The aura
phenomena are explained by the theory of cortical spread-
ing depression, a sustained neuronal depolarisation that
starts at the posterior part of the brain, and then spreads
across the cerebral cortex, generating a transient spike activ-
ity which is followed by a suppression that can last for
minutes (Lauritzen, 1987, 1994).
How the aura relates to the headache is a matter of
speculation, but the spreading depression is likely to be the
key event for the episodic activation of the trigeminovascu-
lar system. A dysfunction of brainstem nuclei involved in
the central control of pain might exert a permissive role by
favouring central trigeminal hyperexcitability (Pietrobon &
Striessnig, 2003). If the theory of spreading depression
holds, the question emerges why the sufferer’s brain is espe-
cially susceptible to it.
Genetic and Environmental Influences 
on Migraine: A Twin Study Across 
Six Countries
Elles J. Mulder1, Caroline van Baal1, David Gaist2, Mikko Kallela3, Jaakko Kaprio7, Dan A. Svensson4, 
Dale R. Nyholt5, Nicholas G. Martin5, Alex J. MacGregor6, Lynn F. Cherkas6, Dorret I. Boomsma1, 
and Aarno Palotie8
1 Dept of Biological Psychology,Vrije Universiteit,Amsterdam,The Netherlands
2 University of Southern Denmark, Odense & Dept of Neurology, Odense University Hospital, Denmark
3 Helsinki University Central Hospital, Finland
4 Karolinska Institutet Stockholm, Sweden
5 The Queensland Institute of Medical Research, Brisbane,Australia
6 Twin Research and Genetic Epidemiology Unit, St Thomas’ Hospital, London, UK;
7 Dept of Public Health, University of Helsinki & Dept of Mental of Health, National Public Health Institute, Helsinki, Finland;
8 The Finnish Genome Center and the Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland
Various biochemical abnormalities have been described
in migraine: chronically low systemic levels of serotonin
(Ferrari & Saxena, 1993), mitochondrial defects (Barbirolli
et al., 1992), magnesium deficiency (Welch & Ramadan,
1995), dysfunctional ion channels (Ophoff et al., 1996,
1997), increased membrane instability (Joutel et al., 1996;
Welch, 1998), central sensitisation of trigeminal fibers
(Burstein & Woolf, 2000), excessive excitation due to
abnormal release of excitatory neurotransmitters, and
reduced intracortical inhibition (see Pietrobon & Striessnig,
2003). Many of these findings seem to justify the hypothe-
sis of a hyperexcitable brain in migraine.
Genes and Environment
It is quite a common event for anyone to have one or two
migraine attacks sometime in life but it is the recurrence of
attacks that is clinically relevant and qualifies migraine as a
disease. Genes could predispose to this recurrence by
setting the brainstem pain pathways in a hypersensitive
state and thereby lowering the threshold for the manifesta-
tion of migraine. This could render a migraine sufferer
sensitive to environmental factors, which could affect the
frequency of attacks. Indeed, stress, weather changes, men-
strual cycle, and excessive sunlight are leading trigger
factors (Robbins, 1994), and lack of sleep and alcohol use
can increase the number of attacks. 
Migraine is under substantial genetic control as several
lines of research indicate. A syndrome as diverse as
migraine is unlikely to be a single gene disorder although a
few rare autosomal migraine traits as well as extensive
familial clustering have been described. Segregation studies
have pointed towards a multifactorial inheritance for the
common forms of migraine (Russell et al., 1995).
Complicating factors in genetic epidemiological studies of
migraine are the high prevalence (migraine might occur in
several family members just by chance), the absence of
simple markers for migraine, as well as the change and het-
erogeneity of the diagnostic criteria. Peroutka and Howell
(1996) studied 255 patients who had migraine without
aura according to the International Headache Society (IHS)
criteria, and found that in 91% at least one of the parents
had IHS migraine, suggesting a dominant mode of inheri-
tance (Kalella, 2000).
A common finding in twin studies of migraine is that
monozygotic (MZ) twins show roughly twice the concor-
dance rates than dizygotic (DZ) twins (MZ: 32–48%; DZ:
12–31%; Kallela, 2000, p. 9) indicating the importance of
genes. The fact that the concordance rate in MZ twins
never reaches 100% illustrates an influence of the environ-
ment. Quantitative genetic modelling of twin data
quantifies the contribution of genes and environment,
showing that the relative importance of genes (heritability)
to the liability of migraine is 40–60% and that the contri-
bution of non-shared environmental factors is 35–55% but
shared environmental factors seem to have no impact at all.
(Gervil et al., 1999; Honkasalo et al., 1995; Larsson et al.,
1995; Ulrich et al., 1999; Ziegler et al., 1998).
In recent years, molecular genetic studies have provided
new and important information on the pathophysiology of
migraine. In a rare, autosomal dominant form of migraine,
Familial Hemiplegic Migraine (FHM) where attacks are pre-
ceded or accompanied with hemiparesis, two disease causing
genes have been identified: CACNA1A on Chromosome 19p
(Ophoff et al., 1994, 1996) and ATP1A2 on Chromosome 
1q (DeFusco et al., 2003). The CACNA1A gene is brain-spe-
cific and codes for the α1A- subunit of neuronal calcium
channels (Ophoff et al., 1996) and the ATP1A2 encodes the
α2 subunit of the Na+/K+ pump. An intriguing fact is that
both molecules associated with FHM are involved in ion
transport, which stimulates the hypothesis that genes coding
for similar cellular pathways are good candidates for the
more common forms of migraine. The role of CACNA1A in
more common types of migraine is, however, controversial
and positive (May et al., 1995; Terwindt et al., 2001) as well
as negative findings (Noble-Topham et al., 2002; Nyholt 
et al., 1998) have been reported. 
GenomEUtwin and the Present Study
The GenomEUtwin project aims to study the population
level significance and contribution of loci and genes identi-
fied in ascertained study samples. Eligible twin pairs that
are affected by migraine as well as their family members
will be approached for genotyping in eight countries, an
effort that will yield significant power to identify new loci
and susceptibility genes. As a first step, the present paper
describes the screening instruments that have been used to
define migraine in the participating countries as well as the
data that are currently at our disposal. We report the
number of MZ and DZ twin pairs and compare sex, age,
prevalence, and heritabilities between the twin samples
from Australia, Denmark, Finland, the Netherlands,
Sweden, and the United Kingdom (UK). Finally, we sum-
marize the available data and perform a simultaneous
analysis to quantify genetic effects, and to test whether the
size and nature of the genetic contribution is similar across
the countries.
Methods
Only complete twin pairs with known zygosity were
selected for the present study. Figure 1 contains a summary
of the instruments that were used in the participating coun-
tries. Mean age and the numbers of twin pairs in each
country are listed in Table 1. 
Subjects and Migraine Classification
Australia. Migraine symptom data were obtained in the
course of an extensive semi-structured telephone interview,
designed to assess physical, psychological and social mani-
festations of alcoholism and related disorders, conducted
with female and male twins born between 1964 and 1971
from the volunteer based Australian Twin Registry (Heath
et al., 2001). The sample was unselected with regard to per-
sonal or family history of alcoholism or other psychiatric or
medical disorders. Interviews relating to their headaches
were conducted between 1996 and 2000 and participants
answering “yes” to ever having “migraine or recurrent
attacks of headache”, then answered a number of questions
based on the IHS diagnostic criteria. The interview yielded
diagnostic criteria for migraine without aura and with aura,
using visual prodromal symptoms as an index of migraine
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with aura. Individuals were diagnosed with or without
migraine according to IHS criteria.
Denmark. The main survey comprised 4314 twins identi-
fied from the population-based Danish Twin Registry
(Skytthe et al., 2002). The twins were successfully home-
interviewed by trained interviewers in 1998 using a
structured interview (Gaist et al., 2000). The structured
interview also contained the following questions screening
for migraine (answer possibilities: Yes or No), which have
previously been validated in a Danish twin population
(Gervil et al., 1998): 1)Have you ever suffered from mig-
raine? 2) Have you ever had visual disturbances of 5 to 60
minutes’ duration followed by headaches? Twins who
answered “Yes” to at least one of the questions were consid-
ered screening positive for migraine. 
Finland. The selection procedures, determination of twin-
ship and assessment of representativeness of the Finnish
Twin Cohort Study are described in detail elsewhere
(Kaprio & Koskenvuo, 2002). The twins were mailed a
questionnaire on medical and psychosocial factors and a
follow-up questionnaire including items on headache and
migraine was sent out in 1981 (Honkasalo et al., 1995).
The younger Twin Cohort (FinnTwin16), born between
1975 and 1979, was contacted within 2 months of their
16th birthday. In the older cohort assessed in 1981, twins
were defined as having migraine if they responded affirma-
tively to the dichotomous question “Have you suffered
from headache attacks during the previous year?”, and if so,
whether the attacks were associated specifically with any of
the following three symptoms: visual disturbances, nausea
or vomiting, and unilateral location, as described by
Honkasalo et al. (1995). The younger twins of the
FinnTwin16 study were asked whether a physician had ever
told them they had had migraine.
The Netherlands. Twins were recruited from the Nether-
lands Twin and Family Register (NTR) that enrols twins
and their spouses, siblings and parents. All receive biannual
health and lifestyle questionnaires that address topics
related to physical and mental health, smoking and drink-
ing, personality and mood. The survey held in 2000 was
used for the present study and items on recurrent headache
and migraine were taken and translated from Gervil et al.
(1998). A total of 6705 subjects (4613 twins, 1477 
siblings, 705 spouses) filled out and returned the quest-
ionnaire. The sample was divided into a younger and an
older cohort, and analysed for a “potential migraine” defin-
ition which was the same as in Denmark. If twins
responded affirmatively either to the question: “Have you
ever had migraine?” or to “Have you ever had visual distur-
bances for 5–60 minutes followed by headache?” they were
considered potential migraineurs. 
Sweden. All twins were recruited from the Swedish Twin
Registry (Pedersen et al., 2002). As part of the Screening
Across Lifespan of Twins (SALT) study, all twins born
between 1886 and 1958 were invited to participate in a
structured telephone interview concerning common health
problems and health related factors. Headache questions
were administered only to the twins born between 1935
and 1958. Data collection was made via Computer Assisted
Telephone Interviews (CATI) performed by trained lay per-
sonnel between 1999 and 2002. 
The International Headache Society classification of
headache phenotypes was used to diagnose migraine (IHS,
1988). The structured migraine interview consisted of a
series of brief questions to be answered “yes”, “no”, “do not
know”, or “refuse to answer”. The sequence of diagnostic
criteria for migraine was as follows: (a) recurrent headache
not associated with infection, fever, or hangover (past or
present); (b) headache attacks lasting somewhere between 4
hours and 3 days if no medication against the pain is taken;
(c) at least two out of four pain features (moderate or severe
intensity, one-sided location, pounding/throbbing quality,
and aggravation by routine physical activity; and (d) at least
one out of two accompanying symptoms (nausea and/or
vomiting, and increased sensitivity to light and sound). A
few respondents who declared that they did not know
whether they had had headache attacks lasting from 4
hours to 3 days, but who fulfilled all other criteria, were
also diagnosed as sufferers of migraine.
UK. All twins were enlisted with the St Thomas’ UK Adult
Twin Registry. This twin database was started in 1992 and
Table 1
Summary of Migraine Definitions and Instruments




Australia IHS Questionnaire* partly confirmed by DNA from blood Yes
Denmark self reported migraine Questionnaire* Not used
Finland3 Physician diagnosis (self reported) Questionnaire*, partly confirmed by DNA from blood No
Finland4 Headache attacks with migrainous features Questionnaire*, partly confirmed by DNA from blood No
Netherlands1,2 self reported migraine Questionnaire*, partly confirmed by DNA 
(blood and buccal swabs) No
Sweden IHS Questionnaire* Yes
UK IHS Questionnaire*, partly confirmed by DNA from blood No
Note: All twin populations were unselected for migraine, headache or any other condition. 1younger and 2 older Dutch cohorts; 3 younger cohort FinnTwin16; 4 older Finnish cohort
Honkasalo (1995) data. *Childhood similarity questionnaires.
twins were recruited by successive media campaigns
without selecting for particular diseases and traits. In the
present sample, all twins are female because the diseases ini-
tially focused on osteoporosis and osteoarthritis, which are
more common in women. All twins receive a series of
postal questionnaires and around half have been assessed in
detail clinically. The UCSD Migraine Questionnaire (Tom
et al., 1994) was incorporated in a larger questionnaire
asking about a range of conditions. Migraine diagnoses
were based on IHS criteria; namely: subject significantly
bothered by recurrent (≥ 5) headaches, not due to a definite
cause (e.g., tumour); pain free intervals between attacks,
and if left untreated, headache would last 4–72 hours.
Characteristics of headache include at least 2 of the follow-
ing descriptions “pulsating”, “unilateral”, “severe enough to
stop or decrease activities”, “made worse by physical activ-
ity”. In addition, headache is accompanied by at least 1 of
the following “nausea or vomiting”, “sensitivity to light”,
“sensitivity to noise” (IHS, 1988).
Data Analyses
Migraine data from Australia, Denmark, Finland, the
Netherlands, Sweden, and the UK were dichotomized
(affected / unaffected) and summarized into 2 × 2 contin-
gency tables for monozygotic males (MZM), dizygotic
males (DZM), monozygotic females (MZF), dizygotic
females (DZF), dizygotic opposite sex pairs with male born
first and female second (DOS-MF), or with female born
first (DOS-FM). Finland and the Netherlands provided
two separate sets of contingency tables for their younger
and older cohorts. 
Mx 1.52 offers a maximum likelihood-based model
fitting approach (Neale, 1997) for ordinal data and we used
the appropriate scripts from the GenomEUtwin Mx script
library to carry out the genetic analyses.1 The analyses are
based on liability models, which assume that the dichoto-
mous distribution of migraine reflects an underlying
continuous liability distribution, with a mean of 0 and a
variance of 1. The threshold, which reflects the prevalence
of the disease, is expressed as a z-value of the normal distri-
bution, and divides the area under the curve into the
proportions of affected and unaffected individuals. Each 2
× 2 contingency table has an underlying bivariate distribu-
tion that can be described by two thresholds (for twin 1
and for twin 2) and a correlation between the two liabili-
ties. The tetrachoric correlation between migraine liability
in twin 1 and in twin 2 in each sex by zygosity group is
derived from the areas under the bivariate normal distribu-
tion (Neale & Cardon, 1992). If the tetrachoric
correlations are larger for MZ than for DZ twins (this
means a relatively larger proportion of concordant MZ
than DZ pairs on the observed scale), then genetic influ-
ences will be important (see Posthuma, this issue), because
monozygotic twins share all their genes, whereas dizygotic
twins share on average 50% of their segregating genes.
We first calculated prevalences and tetrachoric correla-
tions for each country from the sex by zygosity contingency
tables and subsequently tested whether: (a) threshold of
twin 1 = threshold of twin 2; (b) threshold of MZ twins =
threshold of DZ twins; and (c) threshold of males = thresh-
old of females. Next, genetic models were fitted to the
available contingency tables of the sex by zygosity groups
for each country. These genetic models included either
additive genetic (A), common environmental (C) and non-
shared environmental influences (E) or additive genetic,
non-shared environmental and non-additive genetic influ-
ences (D). Note that an ADCE model is not identified if
only the data from twins reared together are available, such
as in the present samples. If twin correlations did not
suggest shared environmental influences, model fitting
results are shown for ADE models and reduced models
only, and if twin correlations did not show evidence for
non-additive genetic influences, we only give model fitting
results for ACE and reduced models. The thresholds (i.e.,
prevalences) in the genetic models were equated for twin 1
and twin 2, as well as for MZ and DZ twins, but were dif-
ferent for males and females. Total variances (A + C + E or
A + D + E) were always constrained to be 1.
We tested whether the same genes contribute to
migraine in males and females by comparing models in
which the correlation between the latent genetic factors in
dizygotic opposite sex (DOS) twins was constrained at .5
with models in which this correlation was allowed to be
smaller. If different genes influence the trait in males and
females, this typically results in a lower genetic correlation
than 0.5 in DOS twins. Next, we tested whether the rela-
tive influences of genes and environment were the same for
males and females. Note that this is a test with 2 degrees of
freedom (df): we constrained the total variance (additive
and non-additive genetic variance plus environmental vari-
ance) of the liability scale to be 1 and consequently,
equating two out of three sources of variance across the
sexes implies that the third is equated as well. Next, ACE or
ADE models (with and without sex differences) were
further reduced to AE, CE and E models. The difference in
χ2 between the full and a reduced model is also a χ2 and
provides a likelihood-ratio test of the significance of the
effect that was dropped.
Finally, all contingency tables from all countries were
simultaneously analyzed. In this 56-group analysis, thresh-
olds were allowed to differ between sexes and countries. We
tested whether (i) broad heritabilities (i.e., the standardized
estimate of the summed additive and non-additive genetic
influences) were the same across countries, (ii) the propor-
tion of non-additive genetic influences in broad heritable
variation was the same across countries, and (iii) non-addi-
tive genetic influences could be omitted from the model. 
Results
The total sample size across all participants added to a total
number of 29,717 complete twin pairs who provided
migraine data for the present study. The different samples
show considerable variability in mean age, ranging from 24
years in Finland to 57 in Denmark (Table 1).
Migraine Prevalence
The threshold that divides the liability distribution into
affected and unaffected subjects was the same for first- and
second born twins (twin 1 and twin 2), as well as for MZ
twins and DZ twins. In every country, the thresholds were
425Twin Research October 2003
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Table 1
Age and Numbers of Discordant and Concordant Twin Pairs for Migraine in GenomEUtwin
Age Age MZ MZ MZ DZ DZ DZ OS OS OS
mean range (dis) (con) (non) (dis) (con) (non) (dis) (con) (non) Total Pairs
Australia 30 22–39 242 55 860 217 34 658 156 20 476 2718
Denmark 57 46–68 141 70 451 173 39 391 218 50 349 1882
Finland3 24 23–27 91 17 528 103 10 518 103 5 537 1912
Finland4 41 24–94 257 57 2376 594 58 4845 0 0 0 8187
Netherlands1 25 18–35 118 50 412 87 20 216 61 9 166 1139
Netherlands2 47 36–68 51 31 100 32 10 49 18 4 35 330
Sweden 52 41–64 450 107 2673 750 84 3590 824 49 3594 12121
UK 48 31–62 196 76 430 238 53 435 0 0 0 1428
Total 1377 382 7318 2075 278 10437 1301 124 4956 29,717
Note: Age mean, age range, and number of complete monozygotic (MZ), dizygotic (DZ), and dizygotic opposite sex (OS) twin pairs that are discordant affected (dis), concordant
affected (con), or none affected (non) for survey-based migraine. DZ group only includes same sex pairs. Dutch sample was split in two age groups: 1 18–35, 2 36–68; 3 younger
cohort FinnTwin16; 4 older Finnish cohort Honkasalo (1995) data.
Figure 2
Prevalences in males and females for survey-based migraine. Each country shows three dots of which the middle denotes the mean and the
flanking dots denote the 95% confidence interval. 1younger and 2older Dutch cohorts; 3 younger cohort FinnTwin16; 4 older Finnish cohort
Honkasalo (1995) data. UK provides females only.
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lower in females, reflecting the fact that migraine preva-
lence is higher in females than in males. More specifically,
prevalence is about twice as high in females as in males in
most countries but it is threefold in Sweden and even four-
fold in the older Finnish cohort (Figure 2). 
Twin Correlations
Correlations show some variability between the countries
(Table 2), but the pattern is the same: MZ correlations are
at least twice the size of the DZ correlations. This is a first
indication of a contribution of genes to the liability to
migraine. Genetic non-additivity is suggested by MZ corre-
lations that are more than twice as high as the DZ
correlations, which is the case in Denmark and the young
sample of the Netherlands, and also in Sweden and Finland
where MZ correlations are even more than threefold the
DZ correlations (Table 2). Sex differences in twin correla-
tions seem rather modest but may play a role in some
countries. For instance, the younger Finnish cohort exhibits
very high MZM and low MZF values. Opposite sex corre-
lations and DZ same sex correlations were within a similar
range, which suggests that the same set of migraine-related
genes is expressed in males and females. There seems little
evidence for shared family environment on the resemblance
in migraine between twins.
Sex Differences in Variance Components
We did not find evidence for different genes between males
and females in the liability to migraine, as the correlation
between latent genetic factors was not significantly different
from 0.5 in opposite sex twins. For each country, the esti-
mates for additive genetic (a2), non-additive genetic (d2)
and non-shared environmental variance (e2) were the same
for males and females (maximum χ2 difference between
these models was 3.41, df = 2) except for the younger
Finnish twins (Table 3) where additive genetic effects were
larger in females and non-additive genetic effects were
larger in males. 
Table 2
Twin Correlations for Survey-based Migraine
MZM DZM MZF DZF DOSMF DOSFM MZ DZ
Australia .45 .29 .30 .09 .10 .25 .34 .15
Denmark .61 .24 .53 .13 .25* — .56 .21
Finland3 .74 .08 .26 .19 .06* — .41 .12
Finland4 .54 .06 .50 .25 — — .51 .22
Netherlands1 .32 –.09 .57 .34 .16 .08 .53 .22
Netherlands2 .41 .37 .55 .24 .46 .07 .52 .28
Sweden .33 .06 .46 .15 .04 .17 .44 .13
UK — — .42 .17 — — .42 .17
Note: Tetrachoric correlations given for monozygotic (MZ), dizygotic (DZ) same sex pairs and dizygotic opposite sex pairs (DOS) separated for males (M) and females (F). DOSMF:
male born first; DOSFM: female born first. Last two columns denote mean MZ and DZ (including OS) correlations. Dutch sample was split in two age groups: 1 18–35, 2 36–68; 3
younger cohort FinnTwin16; 4 older Finnish cohort Honkasalo (1995) data. * DOS pairs were always ordered as male-female, regardless of birth order.
Table 3
ADE Models with Sex Differences for Survey-based Migraine
χ 2 df p AIC a2m a2f d2m d2f e2m e2f Tmales Tfemales
Australia ADE 12.18 12 1 –11.82 .46 .19 .01 .10 .53 .71 1.35 0.83
∆χ2 2.43 2
Denmark ADE 13.05 9 1 –4.95 .42 .24 .20 .29 .38 .48 1.08 0.48
∆χ 2 0.89 2
Finland3 ADE 2.48 9 1 –15.52 .02 .28 .71 .00 .27 .72 1.62 1.14
∆ χ 2 6.84* 2
Finland4 ADE 0.88 6 0.99 –11.12 .00 .49 .53 .01 .47 .50 1.96 1.28
∆χ 2 1.66 2
NL1 ADE 16.35 12 1 –7.65 .08 .57 .21 .00 .70 .43 1.19 0.76
∆χ 2 3.41 2
NL2 ADE 5.74 12 1 –18.26 .44 .55 .00 .00 .56 .45 0.95 0.41
∆χ 2 .19 2
Sweden ADE 18.01 12 1 –5.99 .04 .13 .29 .33 .67 .54 1.69 1.02
∆χ 2 2.1 2
Note: Models with sex differences and with different prevalences (m = males; f = females). χ2 differences are given between ADE models with and without sex differences. Genetic
correlation fixed at 0.5 for opposite sex twins. NL: Dutch sample was split in two age groups: 1 18-35,2 36–68;3 younger cohort FinnTwin6; 4 older Finnish cohort Honkasalo (1995)
data; T =  threshold (in Z-values); * significant χ2 difference. UK provided females only and is not included.
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Non-additive Genetic Variance
We proceeded with the models without sex differences in
genetic architecture for every country. We subsequently
tested for non-additive genetic influences, which were
larger than zero in all samples except for the older Dutch
cohort. The AE model appeared to be most appropriate for
almost every sample but the ADE model fitted best to the
Swedish data (Table 4). The total genetic effects (broad her-
itability) range from 34% (Australia) to 57% (Denmark).
Within this broad heritability, 0% (older Dutch twins) to
84% (Sweden) is accounted for by non-additive effects. 
Simultaneous Analysis
An analysis was performed on all available contingency
tables simultaneously to test whether heritabilities were the
same across the countries and to increase the probability to
detect effects of non-additive genetic variance. The ADE
model was fitted to the data for 29,717 twin pairs from all
countries. Migraine prevalences appeared different across
countries and across sexes in the univariate analyses (see
confidence intervals in Figure 2), so this was maintained in
the simultaneous analysis. Broad heritabilities could be
equated across countries (χ27 = 10.76, p = 0.15). None of
the estimates from the individual countries differed signifi-
cantly from the broad heritability point estimate of 46%. 
If non-additive genetic influences were omitted from the
model, the fit was significantly worse (χ21 = 8.30). The pro-
portions of non-additive genetic effects in broad heritability
were not significantly different across the countries 
(χ27 = 5.25, p = 0.63). Overall, additive heritability is 21%
(CI = 6–36%) and non-additive heritability is 25% 
(CI = 8–42%). 
The power to detect non-additive genetic effects (size of
25%) is very low (12–32%) in each country given its
sample size and migraine prevalence. It appeared unlikely
to detect non-additivity of this magnitude in any country
except Sweden where the power is reasonable (59%). The
power to detect non-additive effects of this magnitude rises
to over 90% in the total sample size. 
Discussion
The aim of GenomEUtwin is to identify loci and suscepti-
bility genes that are involved in migraine. The main
purpose of the present study was, therefore, to describe the
migraine instruments and twin samples that are currently
available from Australia, Denmark, Finland, the
Netherlands, Sweden, and the UK, and to compare preva-
lences and heritabilities before standardisation. The number
of complete twin pairs that were at our disposal for the
present study added to a total of 29,717.
Migraine was ascertained using questionnaires that dif-
fered between most countries. Sweden, the UK, and
Australia had IHS-based migraine, Finland used headache
attacks with migraine features in the older cohort, self-
reported “having ever received a migraine diagnosis by a
physician” in the younger cohort, and Denmark and the
Netherlands used self-reported “ever had migraine”, or
“ever had headache attacks with visual prodroma”.
Interpretation of inter-country differences with respect to
prevalence and heritability has to be tempered by the fact
that these results are confounded to some extent by differ-
ences in diagnostic accuracy, age, and cultural differences in
the reporting of pain. Despite these differences, the ques-
tionnaires have in common that subjects that screened
positive are at risk for migraine. 
Denmark and the Netherlands used the same, and most
liberal, criteria and showed the highest prevalences in
females (32% and 34%, respectively), whereas the lowest
prevalence was found in the younger and older Finnish
Table 4
ADE and AE Models Without Sex Differences for Survey-based Migraine
χ 2 df p AIC a2 d2 e2 h2
Australia ADE 14.61 14 .41 –13.39 .27 (.00–.44) .07 (.00–.45) .66 (.55–.77) .34 (.45–.23)
AE 14.68 15 .47 –15.32 .33 (.23–.43) — .67 (.57–.77) .33 (.43–.23)
Denmark ADE 13.94 11 .24 –8.06 .30 (.00–.61) .27 (.00–.65) .44 (.33–.56) .56 (.67–.44)
AE 15.15 12 .23 –8.85 .53 (.42–.63) — .47 (.37–.58) .53 (.63–.42)
Finland3 ADE 9.32 11 .59 –12.68 .09 (.00–.51) .32 (.00–.57) .59 (.43–.78) .41 (.57–.22)
AE 10.02 12 .61 –13.98 .37 (.21–.52) — .63 (.48–.79) .37 (.51–.21)
Finland4 ADE 2.54 8 .96 –13.46 .38 (.02–.57) .12 (.00–.52) .49 (.41–.59) .51 (.59–.41)
AE 2.91 9 .97 –15.09 .49 (.41–.57) — .51 (.43–.59) .49 (.57–.41)
NL1 ADE 19.76 14 .14 –8.24 .33 (.00–.63) .20 (.00–.65) .47 (.35–.61) .53 (.65–.39)
AE 20.07 15 .17 –9.93 .52 (.39–.63) — .48 (.37–.61) .52 (.63–.39)
NL2 ADE 5.93 14 .97 –22.07 .52 (.00–.69) .00 (.00–.68) .48 (.31–.68) .52 (.69–.32)
AE 5.93 15 .98 –24.07 .52 (.32–.69) — .48 (.31–.68) .52 (.69–.32)
Sweden ADE 20.11 14 .13 –7.89 .07 (.00–.31) .37 (.09–.51) .56 (.49–.64) .44 (.51–.36)
AE 26.75 15 .03 –3.25 .38 (.31–.45) — .62 (.55–.69) .38 (.45–.31)
UK5 ADE 1.96 3 .58 –4.04 .26 (.00–.51) .15 (.00–.52) .58 (.47–.70) .42 (.53–.30)
AE 2.23 4 .69 –5.77 .41 (.29–.51) — .59 (.49–.71) .41 (.51–.29)
Note: Models without sex differences and with different prevalences. Estimates and 95% confidence intervals are given for a2, d2, e2, and h2 (1-e2). Genetic correlation fixed at 0.5
for opposite sex twins; Dutch sample was split in two age groups: 1 18–35, 2 36–68; 3 younger cohort FinnTwin16; 4 older Finnish cohort Honkasalo (1995) data; 5 females only.
cohorts (13% and 10%, respectively). Prevalence is known
to reach its maximum in mid-life (Breslau & Rasmussen,
2001), and in line with this we demonstrated a 10% rise
when comparing the younger with the older Dutch cohort.
All samples showed a prevalence that is more than twice as
high in females as in males, which is a common finding
(Breslau & Rasmussen, 2001). It must be emphasized that,
from a mathematical point of view, incidence of a trait in
the population provides no information about its heritabil-
ity (Lynch & Walsh, 1998, p. 735). 
Non-shared environment and genes contribute signifi-
cantly to the liability to migraine, as has been shown by
many other studies. The AE model yielded the best fit in
every country but there was also some indication of genetic
dominance. This was only significant in Sweden where the
ADE model provided the best fit. Environmental effects
were substantial, ranging from just under 50% (Denmark
and both Dutch cohorts) to 66% (Australia). Diet or lower
temperatures might be protective against the manifestation
of migraine in countries with low prevalence such as
Finland and Sweden. Summed additive and non-additive
genetic effects (broad heritability) ranged from 34% to
57%, with lowest estimates in Australia, and highest esti-
mates in the older cohort of Finland, the Netherlands, and
Denmark. It is interesting to note that migraine instru-
ments of Denmark and Netherlands were characterized by
high prevalence as well as high heritability, whereas Finland
and Sweden have low prevalences and heritabilities. Further
analyses by GenomEUtwin may resolve whether differences
in the estimated prevalence and heritability of the liability
to migraine across nations is because of measurement error,
environmental exposures, or variation in allele frequencies.
The proportion of non-additivity in broad heritability
ranged from zero (older Dutch twins) to 0.84 in Sweden
where the power to detect dominance is by far the largest
(0.59) followed by the older Finnish cohort (0.32). It
became even less likely to detect non-additive genetic influ-
ences in other countries. We performed a simultaneous
analysis on all available data, resulting in significant addi-
tive genetic effects (21%), non-additive genetic effects
(25%) and non-shared environmental effects (54%). We
did not detect differences in the size and nature of genetic
effects between the countries, although it should be noted
that insufficient power might contribute to this. 
Non-additive genetic variation results from interaction
effects of either the two homologous alleles that define the
genotype at a locus (dominance) or between genotypes at
separate loci (epistasis). The presence of non-additive
genetic effects could have implications for linkage analyses
(see Posthuma, this issue) as only twin pairs with IBD-
status = 2 will be informative. Although the validity of
simultaneously analyzing such heterogenous migraine defi-
nitions might be questionable, we argue that it at least
provides information on migraine risk. The presence of
non-additivity should be confirmed, however, after
migraine is defined with the same instrument in every
country.
To gain optimally from the large number of the twin
pairs that are available, GenomEUtwin will need to
homogenize the migraine definition and use a validated
migraine instrument to screen for migraine with and
without aura in the general population. Non-specified
migraine was analysed in the present study, but in the
future the two migraine subtypes will be distinguished. We
hope to make a significant contribution to the active dis-
cussion as to whether these subtypes belong to the same
pathogenic entity. Clinical, laboratory, radiological or other
tests to confirm the diagnosis are not available and it is
hugely impractical to arrange face-to-face interviews
between patients and neurologists to obtain a uniform clin-
ical examination and diagnosis in a population of the
magnitude represented by our combined sample. We will
therefore have to use questionnaires that might be sup-
ported by telephone interviews. 
IHS criteria are widely used to diagnose migraine and
represent the expert opinion of clinicians on what charac-
terises migraine. These criteria have been shown to be
exhaustive and valid in clinical practice (Iversen et al., 1990;
Rasmussen et al., 1991), but they certainly are not flawless
(Blau, 1993). Still, the IHS criteria have been a huge step
forward in migraine research and they will be the starting
point in harmonizing and defining migraine across coun-
tries. It is large population-based genetic studies, such as
GenomEUtwin, that will be able to determine the true
inherited core of these criteria and may contribute to their
future refinement. 
GenomEUtwin aims to identify susceptibility loci and
underlying genes in migraine with and migraine without
aura after defining and homogenizing the diagnostic crite-
ria. The initial genome scan will be carried out first in
concordant DZ twin pairs, and twins including monozy-
gotic twins and their family members will be added. A large
population-based genetic study such as GenomEUtwin
provides a great opportunity to fine tune the diagnostic
IHS criteria and identify the genes that are involved in
complex diseases such as migraine.
Endnote
1 Mx scripts can be retrieved from the GenomEUtwin Mx
script library (www.psy.vu.nl/mxbib).
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